Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2019-11-27 Board/Management Inform…
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
List of Directors and their Roles and Functions
Board/Management Information Classification · 100% confidence The document lists the members of the board of directors and their roles and functions, including details about board committees. It does not contain financial data, earnings, or report content. It is an announcement related to the company's board structure and management composition. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused solely on board information, confirming this classification.
2019-11-27 English
Terms of Reference of the Remuneration and Appraisal Committee of the Board
Remuneration Information Classification · 95% confidence The document is titled 'TERMS OF REFERENCE OF THE REMUNERATION AND APPRAISAL COMMITTEE OF THE BOARD' and details the responsibilities, composition, procedures, and governance of the Remuneration and Appraisal Committee. It focuses on remuneration policies, appraisal standards, committee meetings, voting, and confidentiality related to directors and senior management. There is no financial data, earnings information, or report publication. The content is about governance and remuneration structure rather than a report or announcement of financial results. This matches the definition of Remuneration Information filings, which detail compensation for top executives and directors.
2019-11-27 English
Terms of Reference of the Nomination Committee of the Board
Governance Information Classification · 100% confidence The document is titled 'Terms of Reference of the Nomination Committee of the Board' for Pharmaron Beijing Co., Ltd. It details the structure, responsibilities, procedures, and governance of the Nomination Committee, which is a board committee responsible for nominating directors and senior management. The content focuses on governance practices, committee composition, meeting procedures, and duties related to board nominations. There is no financial data, earnings information, or regulatory filings about financial results. It is not an announcement of a report but a governance document outlining internal rules and committee terms. Therefore, this document fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2019-11-26 English
Terms of Reference of the Audit Committee of the Board
Governance Information Classification · 95% confidence The document is titled 'Terms of Reference of the Audit Committee of the Board' for Pharmaron Beijing Co., Ltd. It outlines the responsibilities, composition, duties, and procedures of the Audit Committee. It references corporate governance standards, listing rules, and internal audit functions. The content is governance-related, focusing on the audit committee's role in overseeing audits, financial reporting, internal controls, and communication with external auditors. It does not contain financial statements, earnings data, or direct financial results. It is not an announcement or a brief notice but a detailed governance document. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2019-11-26 English
Articles of Association
Governance Information Classification · 100% confidence The document is titled 'Pharmaron Beijing Co., Ltd. Articles of Association' and contains detailed chapters and articles about the company's organizational structure, share issuance, shareholder meetings, board of directors, senior management, financial and accounting systems, and other governance-related provisions. It references compliance with the Company Law of the People's Republic of China, Securities Law, and Hong Kong Listing Rules. The content is a legal and governance framework document regulating the company's internal rules, shareholder rights, board structure, and management obligations. It is not a financial report, earnings release, or announcement but a foundational governance document. Therefore, the document fits the category of Governance Information (CGR).
2019-11-26 English
Announcement of Offer Price and Allotment Results
Regulatory Filings Classification · 95% confidence The document is an official announcement from the Hong Kong Stock Exchange (HKEX) regarding the 'IPO Allotment Results' for Pharmaron Beijing Co., Ltd. It provides links to various PDF files detailing the results of share applications for the public offering. Since this document serves as a portal/announcement for the publication of these specific IPO allotment results, it falls under the category of a regulatory filing announcement.
2019-11-26 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.